Home » Topics » BioWorld Science

BioWorld Science
RSS

Allegra now available in Canada

Aug. 6, 1997

Patent protection granted for Hybridon second- and third-generation oligonucleotides

Aug. 6, 1997

Clinical trials begin for cancer diagnostic

Aug. 6, 1997

FDA advisory panel to review Paxene for KS

Aug. 6, 1997

Medicare policy slows Epogen sales

Aug. 6, 1997

Amgen expands Longmont site

Aug. 6, 1997

Paclitaxel approved by FDA for AIDS-related KS

Aug. 6, 1997

Sano and Pharmaceutical Resources amend distribution agreement

Aug. 6, 1997

Company Profile: Bearsden Bio

Aug. 6, 1997

Tripos, Panlabs and Amylin reach metabolic drug screening agreement

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...